晚期发作的全身性红斑狼的渐进性肌肉衰弱和缺食症:一个病例报告
Sho Fukuda1, Kasumi Nishikawa2, Ryuichi Ohta3
1Fmaily Medicine, Unnan City Hospital, Unnan, JPN.
Cureus
|March 24, 2025
概括
在老年人中,晚期发作的全身性红斑狼 (SLE) 可能会出现不寻常的症状,如肌肉虚弱和吞困难. 早期诊断和治疗是这些复杂病例中功能恢复的关键.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 老年病的医生 老年病的医生
背景情况:
- 晚发性全身性红斑狼 (SLE),在50岁以后被诊断出,由于免疫衰老和并发性疾病,它带来了独特的挑战.
- 区分晚发性SLE与老年人的其他疾病对于有效管理至关重要.
研究的目的:
- 在76岁的男性中报告一个晚期发病的SLE病例,突出的神经肌肉参与 (肌肉炎和消化不良).
- 突出老年晚发性SLE的诊断挑战和治疗策略.
- 强调早期识别和多学科护理对优化结果的重要性.
主要方法:
- 综合诊断工作包括实验室检测,自身抗体分析,成像和神经传导研究.
- 临床评估渐进的下肢虚弱和缺食症.
- 使用甲基前尼索隆脉冲疗法,静脉注射免疫球蛋白 (IVIG) 和口服皮质类固醇治疗.
主要成果:
- 晚发性SLE的诊断与显著的神经肌肉,血液学和肺部参与.
- 在迅速治疗后,肌肉强度和吞功能明显改善.
- 在36天内恢复日常生活活动 (ADL) 的独立性,促进转移到康复.
结论:
- 肌肉炎和消化不良可以显著呈现晚发性SLE的症状在老年人中,需要一个高的怀疑指数.
- 及时诊断和积极治疗对于功能恢复和改善生活质量至关重要.
- 为了管理老年人晚发性SLE的复杂性,必须采取多学科的方法.
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.7K
Myasthenia Gravis: Diagnostic Tests
3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Disorders of the Skeletal Muscle
2.2K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.2K
Multiple Sclerosis l: Introduction
20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Myasthenia Gravis ll: Pathophysiology
53
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
53
Esophageal Achalasia
45
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide...
45


